TERESA SALAZAR: Open Payments
NPI 1518636141 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 45 payments from 10 companies in 2025. Trend: 2023 $28 · 2024 $32 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 12 | $418 |
| ABBVIE INC. | 16 | $334 |
| Lundbeck LLC | 4 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| PFIZER INC. | 3 | $62 |
| Averitas Pharma Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| SI-BONE, INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Evoke, QULIPTA, BOTOX, VYEPTI, Belbuca, NURTEC ODT, QUTENZA, UBRELVY.
Industry payments across CO — which companies pay providers there.
